Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06466031
What this trial is testing

Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]

Who this might be right for
Glioblastoma Multiforme
Copernicus Memorial Hospital 189
Testing effectiveness (Phase 2)Study completedNCT00612430
What this trial is testing

Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Duke University 59
Testing effectiveness (Phase 2)Study completedNCT00005081
What this trial is testing

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Study completedNCT00329719
What this trial is testing

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Adult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm
National Cancer Institute (NCI) 115
Early research (Phase 1)Ended earlyNCT04190628
What this trial is testing

Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorBRAF V600 Mutation
ABM Therapeutics Corporation 53
Early research (Phase 1)Active Not RecruitingNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 159
Early research (Phase 1)Active Not RecruitingNCT03961971
What this trial is testing

Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

Who this might be right for
Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Testing effectiveness (Phase 2)Looking for participantsNCT06926075
What this trial is testing

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

Who this might be right for
Prostate CancersBreast CancerLung Cancers+4 more
Filamon LTD 80
Early research (Phase 1)Study completedNCT01180816
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 21
Testing effectiveness (Phase 2)Study completedNCT04051606
What this trial is testing

Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Case Comprehensive Cancer Center 14
Early research (Phase 1)Study completedNCT00613132
What this trial is testing

Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Annick Desjardins 78
Early research (Phase 1)Study completedNCT01308684
What this trial is testing

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Hoffmann-La Roche 22
Early research (Phase 1)Looking for participantsNCT05460507
What this trial is testing

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Who this might be right for
Glioma
Cerenome 40
Early research (Phase 1)Study completedNCT00004041
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT04845919
What this trial is testing

Sonodynamic Therapy With ExAblate System in Glioblastoma Patients

Who this might be right for
Glioblastoma Multiforme
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 5
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Testing effectiveness (Phase 2)WithdrawnNCT05973903
What this trial is testing

Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma

Who this might be right for
GBM
Tel Aviv Medical Center
Not applicableTemporarily pausedNCT03322813
What this trial is testing

ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma

Who this might be right for
Glioma
InSightec 15
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Not applicableWithdrawnNCT04838782
What this trial is testing

Role of Repeat Resection in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma - Category
University of Alberta
Next Page